In 2005, ILO adopted an evaluation policy framework, inspired by internationally accepted norms and standards, that aimed to improve and strengthen the practice of independent evaluation in the ILO.
BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) bearing homologous ...
The production launch date cannot be changed under any circumstances.Testing is important, but the schedule is tight, so ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results